Related Experiment Video
Updated: Jan 21, 2026

Synthesis of Monocyte-targeting Peptide Amphiphile Micelles for Imaging of Atherosclerosis
Published on: November 17, 2017
Inflammation as a Therapeutic Target in Atherosclerosis
Mau T Nguyen1, Sanuja Fernando1,2, Nisha Schwarz1
1Vascular Research Centre, Lifelong Health Theme, South Australian Health and Medical Research Institute (SAHMRI), Adelaide, South Australia 5000, Australia.
Inflammation drives unstable coronary artery disease (CAD) plaques, increasing heart attack risk. Targeting inflammation, not just cholesterol, offers new hope for preventing recurrent cardiovascular events.
Area of Science:
- Cardiovascular Medicine
- Immunology
- Pharmacology
Background:
- Coronary artery disease (CAD) stems from cholesterol plaque buildup, causing significant mortality.
- Inflammation is a key driver of atherosclerotic plaque instability and rupture, leading to myocardial infarction (MI).
- Existing CAD therapies inadequately address plaque inflammation, leaving patients vulnerable to recurrent atherothrombotic events.
Purpose of the Study:
- To review the critical role of inflammation in atherosclerosis pathogenesis.
- To provide an update on emerging anti-inflammatory therapies for CAD.
- To explore strategies for managing plaque inflammation in clinical practice.
Main Methods:
- Literature review of studies on inflammation in atherosclerosis.
- Analysis of clinical trial data for anti-inflammatory agents in CAD.
- Discussion of therapeutic targets and future directions.
Main Results:
- Inflammation significantly contributes to CAD progression and adverse cardiovascular outcomes.
- Targeting specific inflammatory pathways, such as interleukin-1 beta (IL-1β), shows promise.
- The CANTOS trial demonstrated the clinical benefit of reducing inflammation in CAD patients.
Conclusions:
- Inflammation is a crucial therapeutic target for managing coronary artery disease.
- Novel anti-inflammatory agents offer potential to improve outcomes beyond current lipid-lowering strategies.
- Further research is needed to optimize anti-inflammatory treatment strategies for real-world CAD management.
Related Concept Videos
Inflammation
Atherosclerosis III: Management
Atherosclerosis I: Introduction
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
Atherosclerosis IV: Nursing Management
Therapeutic Index

